Organization: Theratechnologies Inc

Theratechnologies spins off new cell therapy firm

Theratechnologies Inc has received $60 million in capital to spin off its ex vivo photodynamic cell therapy program as Celmed BioSciences Inc and has acquired two California-based firms that develop technologies for the treatment of neuro- degenerative diseases. The strategic reorganization is aimed at maximizing asset value and continues the Montreal-based firm’s practise of spinning…